Using two-sample MR, recent studies have reported a 7% reduction in breast cancer risk [28] and a 9% reduction in prostate cancer risk [29] per 1 SD (25 and 30nmol/L) increase in SHBG, respectively. Here, SHBG is linked to prostate carcinoma.